These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 4616079)

  • 1. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
    J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 4. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG; Sparks FC; Morton DL
    Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB; Serrou B
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the immune response by BCG: a review.
    Murahata RI; Mitchell MS
    Yale J Biol Med; 1976 Jul; 49(3):283-91. PubMed ID: 785826
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 10. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications of BCG immunotherapy in patients with cancer.
    Sparks FC; Silverstein MJ; Hunt JS; Haskell CM; Pilch YH; Morton DL
    N Engl J Med; 1973 Oct; 289(16):827-30. PubMed ID: 4763426
    [No Abstract]   [Full Text] [Related]  

  • 13. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
    Aust TR; Massey JA
    Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of immunotherapy of malignant tumors].
    Flad HD; Betzler M; Herfarth C
    Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL; Reif AE; Shklar G
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological adjuvants in cancer immunotherapy.
    Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer immunotherapy with surgery.
    Orita K; Miwa H; Mannami T; Konaga E; Yumura M
    Acta Med Okayama; 1977 Aug; 31(4):217-34. PubMed ID: 145159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.
    Domenick NP
    Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunological aspects of malignant disease.
    Oliver RT
    Practitioner; 1975 Apr; 214(1282):511-521. PubMed ID: 49889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.